The perivascular niche regulates breast tumour dormancy

Nature Cell Biology

Volumn 15, Issue 7, 2013, Pages 807-817

  Ghajar, Cyrus M ^a   Peinado, Héctor ^b   Mori, Hidetoshi ^a   Matei, Irina R ^b   Evason, Kimberley J ^c   Brazier, Hélène ^b   Almeida, Dena ^b   Koller, Antonius ^d   Hajjar, Katherine A ^b   Stainier, Didier Y R ^c,h   Chen, Emily I ^d,e   Lyden, David ^b,f,g   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g Champalimaud Metastasis Programme   (Portugal)

^h MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; LUNG METASTASIS; MICROVASCULAR NICHE; MICROVASCULATURE; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; TUMOR DORMANCY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; BONE MARROW NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM, RESIDUAL; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; STEM CELL NICHE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; ZEBRAFISH;

DANIO RERIO; MUS;

EID: 84880332704     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2767     Document Type: Article

References (64)

1. Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834-846 (2007).
2. Goss, P. E. & Chambers, A. F. Does tumour dormancy offer a therapeutic target? Nat. Rev. Cancer 10, 871-877 (2010).
3. Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312 (2009).
4. Uhr, J. W. & Pantel, K. Controversies in clinical cancer dormancy. Proc. Natl Acad. Sci. USA 108, 12396-12400 (2011).
5. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
6. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
7. Psaila, B. & Lyden, D. The metastatic niche:adapting the foreign soil. Nat. Rev. Cancer 9, 285-293 (2009).
8. Suzuki, M., Mose, E. S., Montel, V. & Tarin, D. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am. J. Pathol. 169, 673-681 (2006).
9. Naumov, G. N. et al. Persistence of solitary mammary carcinoma cells in a secondary site:A possible contributor to dormancy. Cancer Res. 62, 2162-2168 (2002).
10. Pantel, K. et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst. 85, 1419-1424 (1993).
11. Bissell, M. J. & Hines, W. C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17, 320-329 (2011).
12. Boudreau, N., Sympson, C. J., Werb, Z. & Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893 (1995).
13. Spencer, V. A. et al. Depletion of nuclear actin is a key mediator of quiescence in epithelial cells. J. Cell Sci. 124, 123-132 (2011).
14. Weaver, V. M. et al. -4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205-216 (2002).
15. Weaver, V. M. et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245 (1997).
16. Bissell, M. J., Hall, H. G. & Parry, G. How does the extracellular matrix direct gene expression? J. Theor. Biol. 99, 31-68 (1982).
17. Petersen, O. W., Ronnov-Jessen, L., Howlett, A. R. & Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl Acad. Sci. USA 89, 9064-9068 (1992).
18. Braun, S. et al. A pooled analysis of bone marrow micrometastasis in breast cancer. New Engl. J. Med. 353, 793-802 (2005).
19. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572 (2002).
20. Francia, G., Cruz-Munoz, W., Man, S., Xu, P. & Kerbel, R. S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat. Rev. Cancer 11, 135-141 (2011).
21. Paget, S. The distribution of secondary growths in cancer of the breast. Cancer Metast. Rev. 8, 98-101 (1989).
22. Briand, P., Nielsen, K. V., Madsen, M. W. & Petersen, O. W. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res. 56, 2039-2044 (1996).
23. Butler, J. M. et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251-264 (2010).
24. Seandel, M. et al. Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc. Natl Acad. Sci. USA 105, 19288-19293 (2008).
25. Butler, J. M., Kobayashi, H. & Ra-i, S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat. Rev. Cancer 10, 138-146 (2010).
26. Evensen, L. et al. Mural cell associated VEGF is required for organotypic vessel formation. PLoS ONE 4, e5798 (2009).
27. Weinstat-Saslow, D. L. et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511 (1994).
28. Roberts, D. D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 10, 1183-1191 (1996).
29. Ghajar, C. M. et al. The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys. J. 94, 1930-1941 (2008).
30. Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780 (2007).
31. Avraham-Davidi, I. et al. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. Nat. Med. 18, 967-973 (2012).
32. Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 (2009).
33. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012).
34. Oskarsson, T. et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874 (2011).
35. Soikkeli, J. et al. Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to -brillar networks regulating cell adhesion, migration, and growth. Am. J. Pathol. 177, 387-403 (2010).
36. Bierie, B. & Moses, H. L. Tumour microenvironment:TGF-:the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520 (2006).
37. Matsumoto, K., Yoshitomi, H., Rossant, J. & Zaret, K. S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294, 559-563 (2001).
38. Ding, B. S. et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 147, 539-553 (2011).
39. Lammert, E., Cleaver, O. & Melton, D. Induction of pancreatic differentiation by signals from blood vessels. Science 294, 564-567 (2001).
40. Dodge, A. B., Lu, X. & D'Amore, P. A. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth. J. Cell Biochem. 53, 21-31 (1993).
41. Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313 (2008).
42. Kobayashi, H. et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12, 1046-1056 (2010).
43. Shen, Q. et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340 (2004).
44. Ding, L., Saunders, T. L., Enikolopov, G. & Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462 (2012).
45. Bandyopadhyay, S. et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat. Med. 12, 933-938 (2006).
46. Calabrese, C. et al. A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82 (2007).
47. Franses, J. W., Baker, A. B., Chitalia, V. C. & Edelman, E. R. Stromal endothelial cells directly in-uence cancer progression. Sci. Trans. Med. 3, 66ra65 (2011).
48. Indraccolo, S. et al. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res. 69, 1314-1323 (2009).
49. Panigrahy, D. et al. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J. Clin. Invest. 122, 178-191 (2012).
50. Asosingh, K. et al. Nascent endothelium initiates th2 polarization of asthma. J. Immunol. 190, 3458-3465 (2013).
51. Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740 (2001).
52. Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
53. DeNardo, D. G. et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91-102 (2009).
54. Folkman, J. Angiogenesis:an organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273-286 (2007).
55. Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943-953 (2010).
56. Brooks, P. C., Clark, R. A. & Cheresh, D. A. Requirement of vascular integrin -v-3 for angiogenesis. Science 264, 569-571 (1994).
57. Stratman, A. N., Davis, M. J. & Davis, G. E. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 117, 3709-3719 (2011).
58. Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Meth. 4, 359-365 (2007).
59. Pitulescu, M. E., Schmidt, I., Benedito, R. & Adams, R. H. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 5, 1518-1534 (2010).
60. Herbert, S. P. et al. Arterial-venous segregation by selective cell sprouting:an alternative mode of blood vessel formation. Science 326, 294-298 (2009).
61. Nicoli, S. & Presta, M. The zebra-sh/tumor xenograft angiogenesis assay. Nat. Protoc. 2, 2918-2923 (2007).
62. Baluk, P., Morikawa, S., Haskell, A., Mancuso, M. & McDonald, D. M. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163, 1801-1815 (2003).
63. Tanner, K., Mori, H., Mroue, R., Bruni-Cardoso, A. & Bissell, M. J. Coherent angular motion in the establishment of multicellular architecture of glandular tissues. Proc. Natl Acad. Sci. USA 109, 1973-1978 (2012).
64. Beliveau, A. et al. Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo. Genes Dev. 24, 2800-2811 (2010).